BioCryst Pharmaceuticals Long Term Deferred Assets (Quarterly) Trends

BioCryst Pharmaceuticals, Inc. (BCRX)

6.67 +0.01 (+0.15%) USD | NASDAQ | Jan 20, 16:00

6.67 0.00 (0.00%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for BCRX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Astria Therapeutics, Inc.	--
Hologic, Inc.	--
Bruker Corp.	--
Viatris, Inc.	Upgrade
KalVista Pharmaceuticals, Inc.	--